Influence of the central nucleus of the amygdala on the content of corticotropin-releasing factor in the median eminence
- PMID: 2785662
- DOI: 10.1159/000125125
Influence of the central nucleus of the amygdala on the content of corticotropin-releasing factor in the median eminence
Abstract
The central nucleus of the amygdala possesses numerous neurons containing corticotropin-releasing factor (CRF). This study demonstrates a striking decrease of the CRF-like immunoreactivity in the median eminence at both 1 and 2 weeks after bilateral lesions of the amygdaloid central nucleus. Lesion of the amygdaloid central nucleus did not alter the neurophysin-like immunoreactivity in the internal zone of the median eminence, indicating the integrity of the efferent neurophysin-containing fibers of the supraoptic and paraventricular hypothalamic nuclei. However, there was a concomitant decrease of neurophysin and CRF-like immunoreactivity in the external zone of the median eminence. These results substantiate the hypothesis that the amygdaloid central nucleus can influence the content of CRF-like material in the median eminence via a multisynaptic pathway involving the synthesis of CRF at the level of the paraventricular nucleus of the hypothalamus. The exact mechanism by which lesion of the amygdaloid central nucleus influences the CRF content in the median eminence remains to be determined.
Similar articles
-
Immunoreactive corticotropin-releasing hormone in the hypothalamoinfundibular tract.Neuroendocrinology. 1983 Jun;36(6):415-23. doi: 10.1159/000123492. Neuroendocrinology. 1983. PMID: 6348576
-
Distribution of corticotropin-releasing factor in rat brain.Fed Proc. 1985 Jan;44(1 Pt 2):215-9. Fed Proc. 1985. PMID: 3871409
-
Potential corticotropin-releasing factor pathways in the rat brain as determined by bilateral electrolytic lesions of the central amygdaloid nucleus and the paraventricular nucleus of the hypothalamus.J Neuroendocrinol. 1993 Feb;5(1):95-8. doi: 10.1111/j.1365-2826.1993.tb00367.x. J Neuroendocrinol. 1993. PMID: 8485547
-
Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress.Ann N Y Acad Sci. 1993 Oct 29;697:53-60. doi: 10.1111/j.1749-6632.1993.tb49922.x. Ann N Y Acad Sci. 1993. PMID: 8257022 Review.
-
Allostasis, amygdala, and anticipatory angst.Neurosci Biobehav Rev. 1994 Fall;18(3):385-96. doi: 10.1016/0149-7634(94)90051-5. Neurosci Biobehav Rev. 1994. PMID: 7984356 Review.
Cited by
-
Down-regulation of hypothalamic corticotropin-releasing hormone messenger ribonucleic acid (mRNA) precedes early-life experience-induced changes in hippocampal glucocorticoid receptor mRNA.Endocrinology. 2001 Jan;142(1):89-97. doi: 10.1210/endo.142.1.7917. Endocrinology. 2001. PMID: 11145570 Free PMC article.
-
Neuroplasticity of the hypothalamic-pituitary-adrenal axis early in life requires recurrent recruitment of stress-regulating brain regions.J Neurosci. 2006 Mar 1;26(9):2434-42. doi: 10.1523/JNEUROSCI.4080-05.2006. J Neurosci. 2006. PMID: 16510721 Free PMC article.
-
Lesions of the central amygdala and ventromedial medulla reduce bladder hypersensitivity produced by acute but not chronic foot shock.Brain Res. 2017 Nov 15;1675:1-7. doi: 10.1016/j.brainres.2017.08.032. Epub 2017 Sep 1. Brain Res. 2017. PMID: 28867481 Free PMC article.
-
Neurobiology of the stress response early in life: evolution of a concept and the role of corticotropin releasing hormone.Mol Psychiatry. 2001 Nov;6(6):647-56. doi: 10.1038/sj.mp.4000942. Mol Psychiatry. 2001. PMID: 11673792 Free PMC article. Review.
-
Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits.Mol Neurobiol. 1998 Aug;18(1):1-22. doi: 10.1007/BF02741457. Mol Neurobiol. 1998. PMID: 9824846 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources